SCHEMBL4131902

SCHEMBL4131902

CC(C)(C)OC(=O)NC[C@@H]1C[C@H]1c1ccccc1-c1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.54
CTSK P43235 1/20 0.44
GRM2 Q14416 1/20 0.41
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNA5 P22460 3/20 0.39
KCNH2 Q12809 1/20 0.39
MTNR1B P49286 1/20 0.39
ACACB O00763 4/20 0.38
ACACA Q13085 2/20 0.38
DRD2 P14416 1/20 0.38
RORC P51449 2/20 0.38
MALT1 Q9UDY8 1/20 0.38
CHRM3 P20309 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4131900 1.00 HTR2C (0.54) HTR2CCTSKGRM2SLC6A4SLC6A3
SCHEMBL5343070 0.94 HTR2C (0.48) HTR2CCTSKGRM2SLC6A4SLC6A3
SCHEMBL4128708 0.90 CNR1 (0.42) HTR2CSLC6A4SLC6A3MTNR1BACACB
SCHEMBL4128706 0.90 CNR1 (0.42) HTR2CSLC6A4SLC6A3MTNR1BACACB
SCHEMBL4131945 0.89 HTR2C (0.41) HTR2CSLC6A4MTNR1BACACBACACA
SCHEMBL4131941 0.89 HTR2C (0.41) HTR2CSLC6A4MTNR1BACACBACACA
SCHEMBL5312992 0.85 HTR2C (0.39) HTR2CSLC6A4SLC6A3MTNR1BACACB
SCHEMBL5313624 0.84 HTR2C (0.39) HTR2CSLC6A4SLC6A3MTNR1BACACB
SCHEMBL4126563 0.84 SLC6A3 (0.44) HTR2CCTSKGRM2SLC6A4SLC6A3
SCHEMBL4126559 0.84 SLC6A3 (0.44) HTR2CCTSKGRM2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A HTR2C 1/4885CTSK 4615/4885GRM2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.